SPPI NASDAQ
Spectrum Pharmaceuticals, Inc.
1W: +0.0%
1M: +8.7%
3M: +5.6%
1Y: +21.2%
3Y: -71.8%
5Y: -95.3%
$1.02
Last traded 2023-07-31 — delisted
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Supply Chain Overview
4 relationships0
As Filer
counterparties named
4
As Counterparty
mentioned by others
2023-04-25
Earliest Filing
2025-10-10
Latest Filing
Mentioned As Counterparty
4 mentionsOther companies that named SPPI in their SEC 8-K filings.
| Filed By | Relationship | Summary | Filing Date | SEC |
|---|---|---|---|---|
| ASRT Assertio Holdings, Inc. | supplier | Wholly owned subsidiary of Assertio Holdings, Inc. that entered into an amended supply agreement for ROLVEDON drug subst | 2025-10-10 | View |
| ASRT Assertio Holdings, Inc. | acquirer | Target of acquisition by Assertio Holdings, Inc. | 2023-10-10 | View |
| ASRT Assertio Holdings, Inc. | acquirer | Target company acquired by Assertio Holdings, Inc. via a merger agreement. | 2023-08-01 | View |
| ASRT Assertio Holdings, Inc. | acquirer | Target company in the merger agreement with Assertio Holdings, Inc. | 2023-04-25 | View |
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text.
Covers 2021–2026. View on SEC EDGAR